- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis ; volume:10 ; number:5 ; day:3 ; month:7 ; year:2023 ; pages:1119-1125 ; date:10.2023
Rheumatology and therapy ; 10, Heft 5 (3.7.2023), 1119-1125, 10.2023
- Creator
-
Lubrano, Ennio
Scriffignano, Silvia
Perrotta, Fabio Massimo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-023-00574-w
- URN
-
urn:nbn:de:101:1-2023110809503917030305
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lubrano, Ennio
- Scriffignano, Silvia
- Perrotta, Fabio Massimo
- SpringerLink (Online service)
Other Objects (12)
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat